Use and cardiovascular safety of transdermal and other granisetron preparations in cancer management

Use and cardiovascular safety of transdermal and other granisetron preparations in cancer management

Jay W Mason,1 Thomas E Moon2 1School of Medicine, University of Utah, Salt Lake City, UT, 2Tarizona eHealth Services, Inc, Emeryville, CA, USA Abstract: 5-HT3 antagonists have been available as oral and intravenous preparations for decades. The availability more recently of transdermal granisetron a...

Full description

Bibliographic Details
Main Authors: Mason JW, Moon TE
Format: Article
Language:English
Published: Dove Medical Press 2013-07-01
Series:Cancer Management and Research
Online Access:http://www.dovepress.com/use-and-cardiovascular-safety-of-transdermal-and-other-granisetron-pre-a13822
id doaj-d383dfe2c9ac4f6f84b8ded446bf1d3e
record_format Article
spelling doaj-d383dfe2c9ac4f6f84b8ded446bf1d3e2020-11-24T23:46:17ZengDove Medical PressCancer Management and Research1179-13222013-07-012013default179185Use and cardiovascular safety of transdermal and other granisetron preparations in cancer managementMason JWMoon TEJay W Mason,1 Thomas E Moon2 1School of Medicine, University of Utah, Salt Lake City, UT, 2Tarizona eHealth Services, Inc, Emeryville, CA, USA Abstract: 5-HT3 antagonists have been available as oral and intravenous preparations for decades. The availability more recently of transdermal granisetron and the anticipated availability of a subcutaneous granisetron preparation have provided helpful alternatives to patients, and these preparations have been shown to have less potential to prolong QT than other drugs in the class. Keywords: chemotherapy-induced nausea, vomiting, granisetron, QT prolongationhttp://www.dovepress.com/use-and-cardiovascular-safety-of-transdermal-and-other-granisetron-pre-a13822
collection DOAJ
language English
format Article
sources DOAJ
author Mason JW
Moon TE
spellingShingle Mason JW
Moon TE
Use and cardiovascular safety of transdermal and other granisetron preparations in cancer management
Cancer Management and Research
author_facet Mason JW
Moon TE
author_sort Mason JW
title Use and cardiovascular safety of transdermal and other granisetron preparations in cancer management
title_short Use and cardiovascular safety of transdermal and other granisetron preparations in cancer management
title_full Use and cardiovascular safety of transdermal and other granisetron preparations in cancer management
title_fullStr Use and cardiovascular safety of transdermal and other granisetron preparations in cancer management
title_full_unstemmed Use and cardiovascular safety of transdermal and other granisetron preparations in cancer management
title_sort use and cardiovascular safety of transdermal and other granisetron preparations in cancer management
publisher Dove Medical Press
series Cancer Management and Research
issn 1179-1322
publishDate 2013-07-01
description Jay W Mason,1 Thomas E Moon2 1School of Medicine, University of Utah, Salt Lake City, UT, 2Tarizona eHealth Services, Inc, Emeryville, CA, USA Abstract: 5-HT3 antagonists have been available as oral and intravenous preparations for decades. The availability more recently of transdermal granisetron and the anticipated availability of a subcutaneous granisetron preparation have provided helpful alternatives to patients, and these preparations have been shown to have less potential to prolong QT than other drugs in the class. Keywords: chemotherapy-induced nausea, vomiting, granisetron, QT prolongation
url http://www.dovepress.com/use-and-cardiovascular-safety-of-transdermal-and-other-granisetron-pre-a13822
work_keys_str_mv AT masonjw useandcardiovascularsafetyoftransdermalandothergranisetronpreparationsincancermanagement
AT moonte useandcardiovascularsafetyoftransdermalandothergranisetronpreparationsincancermanagement
_version_ 1725493899694178304

Similar Items